Cargando…

Cell-cell contact-induced gene editing/activation in mammalian cells using a synNotch-CRISPR/Cas9 system

Detalles Bibliográficos
Autores principales:	Huang, Hongxin, Zhang, Xin, Lv, Jie, Yang, Hongcheng, Wang, Xinlong, Ma, Shufeng, Shao, Ruoyang, Peng, Xin, Lin, Ying, Rong, Zhili
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Higher Education Press 2020
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7093359/ https://www.ncbi.nlm.nih.gov/pubmed/32002793 http://dx.doi.org/10.1007/s13238-020-00690-1

Ejemplares similares

Engineering Axl specific CAR and SynNotch receptor for cancer therapy
por: Cho, Jang Hwan, et al.
Publicado: (2018)

Author Correction: Engineering Axl specific CAR and SynNotch receptor for cancer therapy
por: Cho, Jang Hwan, et al.
Publicado: (2020)

Post-translational covalent assembly of CAR and synNotch receptors for programmable antigen targeting
por: Ruffo, Elisa, et al.
Publicado: (2023)

Target-Dependent Expression of IL12 by synNotch Receptor-Engineered NK92 Cells Increases the Antitumor Activities of CAR-T Cells
por: Luo, Hong, et al.
Publicado: (2019)

A recombinant adenovirus vector containing the synNotch receptor gene for the treatment of triple-negative breast cancer
por: A, Ruhan, et al.
Publicado: (2023)

Preclinical assessment of the efficacy and specificity of GD2-B7H3 SynNotch CAR-T in metastatic neuroblastoma
por: Moghimi, Babak, et al.
Publicado: (2021)

Engineered circular guide RNAs boost CRISPR/Cas12a- and CRISPR/Cas13d-based DNA and RNA editing
por: Zhang, Xin, et al.
Publicado: (2023)

IMMU-14. SynNotch chimeric antigen receptor (CAR) T-cells as a potential treatment for diffuse intrinsic pontine glioma (DIPG)/diffuse midline glioma (DMG)
por: Ferrerosa, Lauren, et al.
Publicado: (2022)

Engineering macrophages to phagocytose cancer cells by blocking the CD47/SIRPɑ axis
por: Yang, Hongcheng, et al.
Publicado: (2019)

Fast and cloning‐free CRISPR/Cas9‐mediated genomic editing in mammalian cells
por: Manna, Paul T., et al.
Publicado: (2019)

Phase-separated DropCRISPRa platform for efficient gene activation in mammalian cells and mice
por: Ma, Shufeng, et al.
Publicado: (2023)

The Neisseria meningitidis CRISPR-Cas9 System Enables Specific Genome Editing in Mammalian Cells
por: Lee, Ciaran M, et al.
Publicado: (2016)

Bi-PE: bi-directional priming improves CRISPR/Cas9 prime editing in mammalian cells
por: Tao, Rui, et al.
Publicado: (2022)

The Rise of CRISPR/Cas for Genome Editing in Stem Cells
por: Shui, Bing, et al.
Publicado: (2016)

Methodologies and Challenges for CRISPR/Cas9 Mediated Genome Editing of the Mammalian Brain
por: Nishizono, Hirofumi, et al.
Publicado: (2020)

Synergistic engineering of CRISPR-Cas nucleases enables robust mammalian genome editing
por: Chen, Yangcan, et al.
Publicado: (2022)

Targeted activation of diverse CRISPR-Cas systems for mammalian genome editing via proximal CRISPR targeting
por: Chen, Fuqiang, et al.
Publicado: (2017)

Genome editing of immune cells using CRISPR/Cas9
por: Kim, Segi, et al.
Publicado: (2021)

Enhanced Cas12a editing in mammalian cells and zebrafish
por: Liu, Pengpeng, et al.
Publicado: (2019)

Tag-seq: a convenient and scalable method for genome-wide specificity assessment of CRISPR/Cas nucleases
por: Huang, Hongxin, et al.
Publicado: (2021)

Controlled delivery of β-globin-targeting TALENs and CRISPR/Cas9 into mammalian cells for genome editing using microinjection
por: Cottle, Renee N., et al.
Publicado: (2015)

Homology-based repair induced by CRISPR-Cas nucleases in mammalian embryo genome editing
por: Zhang, Xiya, et al.
Publicado: (2021)

Engineered Cas12a-Plus nuclease enables gene editing with enhanced activity and specificity
por: Huang, Hongxin, et al.
Publicado: (2022)

CRISPR/Cas genome editing system and its application in potato
por: Hou, Xin, et al.
Publicado: (2023)

CRISPR/Cas9-Mediated Genome Editing in Cancer Therapy
por: Ding, Shuai, et al.
Publicado: (2023)

Efficient CRISPR/Cas9-based genome editing in carrot cells
por: Klimek-Chodacka, Magdalena, et al.
Publicado: (2018)

Methods and applications of CRISPR/Cas system for genome editing in stem cells
por: Yang, Guang, et al.
Publicado: (2019)

How CRISPR/Cas9 Gene Editing Is Revolutionizing T Cell Research
por: Johansen, Kristoffer Haurum
Publicado: (2022)

Application of CRISPR/Cas9 Nuclease in Amphioxus Genome Editing
por: Su, Liuru, et al.
Publicado: (2020)

CRISPR/Cas9-Mediated Gene Editing in Salmonids Cells and Efficient Establishment of Edited Clonal Cell Lines
por: Strømsnes, Trygve A. H., et al.
Publicado: (2022)

Generating Single Cell–Derived Knockout Clones in Mammalian Cells with CRISPR/Cas9
por: Giuliano, Christopher J., et al.
Publicado: (2019)

Genome editing in mammalian cells using the CRISPR type I-D nuclease
por: Osakabe, Keishi, et al.
Publicado: (2021)

CRISPR-Cas9 DNA Base-Editing and Prime-Editing
por: Kantor, Ariel, et al.
Publicado: (2020)

Therapeutic potential of CRISPR/Cas9 gene editing in engineered T‐cell therapy
por: Gao, Qianqian, et al.
Publicado: (2019)

High-Throughput Genotyping of CRISPR/Cas Edited Cells in 96-Well Plates
por: Nussbaum, Lea, et al.
Publicado: (2018)

CRISPR/Cas: From Tumor Gene Editing to T Cell-Based Immunotherapy of Cancer
por: Azangou-Khyavy, Mohammadreza, et al.
Publicado: (2020)

Efficient CRISPR/Cas9 genome editing with Citrus embryogenic cell cultures
por: Dutt, Manjul, et al.
Publicado: (2020)

CRISPR-Cas3 induces broad and unidirectional genome editing in human cells
por: Morisaka, Hiroyuki, et al.
Publicado: (2019)

Engineering the next-generation of CAR T-cells with CRISPR-Cas9 gene editing
por: Dimitri, Alexander, et al.
Publicado: (2022)

Comparison of DNA targeting CRISPR editors in human cells
por: Huang, Hongxin, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_asjfpnjctbd6r5556vip6aibi8